CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 1,044 enrolled
Drug / intervention
Polyethylene Glycols +2 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02956057
NCT02956057Phase 4Completed

A Head-to-head Comparison of Efficiency and Tolerance of 4-L Polyethylene Glycol and Sodium Picosulphate/ Magnesium Citrate, Polyethylene Glycol/Ascorbate Before Colonoscopy

Tomas Bata Hospital, Czech Republic·interventional·Posted Nov 4, 2016·Updated Oct 28, 2020

In Brief

A Phase 4 clinical trial evaluating Polyethylene Glycols, Natrium picosulfate / Magnesium citrate, and 1 other intervention for Colonoscopy. Completed, enrolled 1,044 participants across 1 site.

Detailed Summary

Study evaluates the efficacy and tolerability of low volume preparations compared with conventional 4L polyethylene glycol prior to colonoscopy

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsColonoscopy
CountriesCzechia

Timeline

Phase 4CompletedFinished
2017201820192020202120222023202420252026
First PostedNov 4, 2016
Enrollment StartNov 12, 2016
Primary CompletionMay 29, 2017
Study CompletionAug 17, 2017
TodayJul 2, 2026
Enrollment to primary: 7 monthsPosted 9.7 years ago

Interventions

Polyethylene Glycolsdrug

Natrium picosulfate / Magnesium citratedrug

Polyethylene glycol / Ascorbic aciddrug